XML 42 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting
 6 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
 
The Company has three reportable segments: Pharmacy Services, Retail Pharmacy and Corporate. The Company’s segments maintain separate financial information for which operating results are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company evaluates its Pharmacy Services and Retail Pharmacy segments’ performance based on net revenue, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. The Company evaluates the performance of its Corporate Segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities.
 
The Pharmacy Services Segment provides a full range of pharmacy benefit management (“PBM”) services including mail service dispensing pharmacies, specialty pharmacy and infusion services, plan design and administration, formulary management, discounted drug purchase arrangements, Medicare Part D services, retail pharmacy network management services, prescription management systems, clinical services, disease management services and medical pharmacy management services. The Company’s customers are primarily employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans and individuals throughout the United States. In addition, through the Company’s SilverScript Insurance Company subsidiary, the Company is a national provider of drug benefits to eligible beneficiaries under the Federal Government’s Medicare Part D program. The Pharmacy Services business operates under the CVS Caremark® Pharmacy Services, Caremark®, CVS Caremark®, CarePlus CVS/pharmacy®, CVS/caremarkTM, CVS/specialtyTM, RxAmerica®, Accordant®, SilverScript®, Novologix® and Coram® names. As of June 30, 2014, the Pharmacy Services Segment operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies, four mail service dispensing pharmacies, and 84 branches and six centers of excellence for infusion and enteral services located in 41 states, Puerto Rico and the District of Columbia.
 
The Retail Pharmacy Segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards and convenience foods through the Company’s CVS/pharmacy®, CVS®, Longs Drugs® and Drogaria Onofre® retail stores and online through CVS.com® and Onofre.com.br. As of June 30, 2014, the Retail Pharmacy Segment included 7,705 retail drugstores (of which 7,647 operated a pharmacy), 17 onsite pharmacies, 860 retail health care clinics, and the online retail websites, CVS.com and Onofre.com.br. The retail drugstores are located in 43 states, the District of Columbia, Puerto Rico and Brazil. The retail health care clinics operate under the MinuteClinic® name, and 852 are located within CVS/pharmacy stores. MinuteClinics utilize nationally-recognized medical protocols to diagnose and treat minor health conditions, perform health screenings, monitor chronic conditions and deliver vaccinations. The clinics are staffed by board-certified nurse practitioners and physician assistants who provide access to affordable care without appointment.
 
The Corporate Segment provides management and administrative services to support the Company. The Corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments.
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
June 30, 2014:
 
 
 
 
 
 
 
 
 
Net revenues
$
21,836

 
$
16,871

 
$
—

 
$
(4,105
)
 
$
34,602

Gross profit
1,195

 
5,299

 
—

 
(170
)
 
6,324

Operating profit (loss)
878

 
1,705

 
(205
)
 
(170
)
 
2,208

June 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
18,800

 
16,139

 
—

 
(3,691
)
 
31,248

Gross profit
963

 
5,005

 
—

 
(127
)
 
5,841

Operating profit (loss)
675

 
1,600

 
(176
)
 
(127
)
 
1,972

Six Months Ended
 

 
 

 
 

 
 

 
 

June 30, 2014:
 

 
 

 
 

 
 

 
 

Net revenues
42,031

 
33,351

 
—

 
(8,091
)
 
67,291

Gross profit
2,129

 
10,483

 
—

 
(346
)
 
12,266

Operating profit (loss)
1,518

 
3,455

 
(395
)
 
(346
)
 
4,232

June 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
37,111

 
32,179

 
—

 
(7,291
)
 
61,999

Gross profit
1,731

 
9,952

 
—

 
(265
)
 
11,418

Operating profit (loss)
1,174

 
3,132

 
(375
)
 
(265
)
 
3,666

Total assets:
 

 
 

 
 

 
 

 
 

June 30, 2014
41,189

 
30,803

 
1,790

 
(1,189
)
 
72,593

December 31, 2013
38,343

 
30,191

 
4,420

 
(1,428
)
 
71,526

Goodwill:
 

 
 

 
 

 
 

 
 

June 30, 2014
21,233

 
6,893

 
—

 
—

 
28,126

December 31, 2013
19,658

 
6,884

 
—

 
—

 
26,542


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.0 billion of retail co-payments for the three months ended both June 30, 2014 and 2013, as well as $4.2 billion of retail co-payments for the six months ended both June 30, 2014 and 2013.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a stand-alone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the intersegment activity described in item (ii) above: net revenues of $1.2 billion and $1.1 billion for the three months ended June 30, 2014 and 2013, respectively, and $2.3 billion and $2.0 billion for the six months ended June 30, 2014 and 2013, respectively; and gross profit and operating profit of $170 million and $127 million for the three months ended June 30, 2014 and 2013, respectively, and $346 million and $265 million for the six months ended June 30, 2014 and 2013, respectively.